Pfizer: Previously Bearish, I'm Converting To A Cautious Bull (Rating Upgrade)

Pfizer's stock has been upgraded by an analyst who previously had a bearish view on the company.

The analyst cites the company's strong pipeline and potential for growth in its biopharmaceuticals business.

Want to stay up to date with the world events at sea or at home?